Skip to main content

ADVERTISEMENT

Joyce Y. Cheng, MD, MHS, MSN, PMHNP-BC

KINECT™-HD2 is an ongoing, long-term open-label study of once-daily valbenazine for chorea associated with Huntington disease. Pre-planned interim analyses indicate early chorea improveme...
10/26/2023